Home›Companies›Biotech & Pharma›IntraBio

IntraBio Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 25, 2024·Suggest an edit

About IntraBio

IntraBio is a private company based in Austin, Texas. It has reported $50,567,575 raised in two offerings on Form D since August 2018.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 7, 2023Mar 25, 2024$40,267,575of $40.9M target37$1.0MEquityRule 506(b)Form D ↗
Jan 26, 2018Aug 20, 2018amended Nov 5, 2020$10,300,000of $21.0M target62$166KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$50,567,575

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on IntraBio's Form D filed Mar 25, 2024.

TF
Taylor Fields
Executive officer
CY
Christian Yegen
Executive officer and director
MF
Mallory Factor
Executive Chairman
ML
Mark Lubkeman
Executive officer
IB
Ian Billington
Executive officer
JM
James Meyers
Executive officer
IR
Ian Rosen
Executive officer
AK
Ali Khan
Director
EF
Elizabeth Factor
Executive officer and director

Sources

  1. SECIntraBio Inc. Form D, filed Aug 20, 2018
  2. SECIntraBio Inc. filing history